House and Senate Appropriators Pledge to Increase Biomedical Research Funding.
Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center
Clinical Trials: NIH Health Plans Association, Agree In Principle to Raise Clinical Trial Enrollment
Cancer Screenings: American Over 50 Urged to Get Colon Caner Tests
Cancer Prevention: HHS Calls for Warning Labels on Cigars, Says Teen Use High
Funding Opportunities: NCI Offers Grant Supplements
Foon To Direct Barrett Center; Hundahl Leads Commission
National Comprehensive Center Network, Quintiles Oncology, To Collaborate On Trials
Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System
Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says
Approvals and Applications: European Committee Signs Off On Paxene for KS reatment
Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms
Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol
Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - In the Headlines: “There’s no one to stand up for NCI right now.”
- Bhattacharya cancels NIH all-hands meeting
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges
